![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PubMed:23667615 / 968-1215
Annnotations
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T10","span":{"begin":0,"end":247},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":247},"obj":"Sentence"}],"text":"We included 64 moderate-severe, steroid-naive COPD patients (24/40 (ex)-smokers, 62±7 years, 46 (31-54) packyears, post-bronchodilator forced expiratory volume in one second (FEV1) 62±9% predicted) at baseline in this randomized, controlled trial."}
Zierdiyeerkenaili_800_3
{"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T6","span":{"begin":46,"end":50},"obj":"DP"}],"text":"We included 64 moderate-severe, steroid-naive COPD patients (24/40 (ex)-smokers, 62±7 years, 46 (31-54) packyears, post-bronchodilator forced expiratory volume in one second (FEV1) 62±9% predicted) at baseline in this randomized, controlled trial."}
yaoziqian_800_3
{"project":"yaoziqian_800_3","denotations":[{"id":"T11","span":{"begin":46,"end":50},"obj":"DP"}],"text":"We included 64 moderate-severe, steroid-naive COPD patients (24/40 (ex)-smokers, 62±7 years, 46 (31-54) packyears, post-bronchodilator forced expiratory volume in one second (FEV1) 62±9% predicted) at baseline in this randomized, controlled trial."}